Dana-Farber Cancer Institute Gains Unprecedented Insight into Cancer Vaccine Clinical Trials with TIBCO Spotfire

“Spotfire quickly gave us a visual analysis of major trends and main clusters of activity, highlighting neglected areas and graphically pointing out the glaring need of many of these cancers for additional vaccine development.” Vladimir Brusic, Dana-Farber CVC’s Director of Bioinformatics

Download This Free Case Study

  

CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.